Allopurinol can cause blood disorders, such as agranulocytosis, aplastic anemia, hemolytic anemia, low platelet levels (thrombocytopenia), and low white blood cell levels (leukopenia).

IV allopurinol, administered prophylactically to patients at high risk of developing hyperuricemia and TLS, prevented an increase in SUA levels in 93% of adults and 92% of children. Toxicities caused ...

Featuring articles on allopurinol and kidney function in type 1 diabetes, the effects of allopurinol on progression of chronic kidney disease, the effect on patient safety of eliminating extended ...